About: http://hub.abes.fr/oup/periodical/annonc/2006/volume_17/issue_5/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/oup/periodical/annonc/2006/volume_17/issue_5/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/annonc/2006/volume_17
has manifestation of work	http://hub.abes.fr/oup/periodical/annonc/2006/volume_17/issue_5/m/print http://hub.abes.fr/oup/periodical/annonc/2006/volume_17/issue_5/m/web
Date Copyrighted	2006
Rights	© 2005 European Society for Medical Oncology © 2006 European Society for Medical Oncology
issue	5
is Is Part Of of	Home treatment for intensive hematological therapies: who will benefit? in this issue Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa Shifting to outpatient management of acute myeloid leukemia: a prospective experience Occupational asbestos exposure: how to deal with suspected mesothelioma cases—the Dutch approach Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective survey Bortezomib (VELCADE®) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients St Gallen guidelines: aromatase inhibitors recommended by name for adjuvant therapy Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis A good death for cancer patients: still a dream? The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata